Status:

COMPLETED

UKA Manual Versus UKA MAKO Robotic

Lead Sponsor:

Washington University School of Medicine

Conditions:

Arthritis

Eligibility:

All Genders

18-75 years

Brief Summary

The purposes of this investigation is to 1) To determine if Robotic-arm assisted UKA (RA-UKA) allows for more accurate component placement than manual UKA (MI-UKA)and 2) prospectively assess the learn...

Detailed Description

Total knee arthroplasty (TKA) is known to have excellent long-term survivorship and clinical success in the management of degenerative joint disease, and remains the primary treatment for patients wit...

Eligibility Criteria

Inclusion

  • All patients who receive a robotic arm assisted UKA using the RIO navigation system will be prospectively included. All patients who have received a medial fixed or mobile UKA performed by surgeons in the Joint Preservation, Resurfacing, and Replacement Service at Washington University will be retrospectively reviewed. Also, all TKAs from a pervious study (IRB 201308057) performed by surgeons in the Joint Preservation, Resurfacing, and Replacement Service at Washington University will be retrospectively reviewed as well.
  • Patient is willing and able to comply with postoperative follow-up requirements and self-evaluations
  • Patient is willing to sign an IRB approved informed consent
  • Patient is at least 18 years of age

Exclusion

  • • Patient has a BMI \< 40
  • Patient is skeletally immature
  • Patient has an active infection or suspected infection in or about the joint
  • Bone stock that is inadequate to support fixation of the prosthesis
  • Neuromuscular disorders, muscular atrophy or vascular deficiency in the affected limb rendering the procedure unjustified.
  • Patients with mental or neurological conditions which may be incapable of following instructions.
  • Blood supply limitations
  • Collateral ligament insufficiency.
  • Patients with prior HTOs or Unis.
  • Patients requiring bilateral knee arthroplasty.

Key Trial Info

Start Date :

February 12 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 7 2024

Estimated Enrollment :

486 Patients enrolled

Trial Details

Trial ID

NCT03447626

Start Date

February 12 2019

End Date

April 7 2024

Last Update

May 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Barnes Jewish Hospital

St Louis, Missouri, United States, 63110